Lab of the Future – News and Features
News
FDA Approves new Roche West Nile Virus Blood Screening Test
According to Roche, automated test helps ensure safety of blood supply by detecting virus earlier in infection cycle.
News
HTS Basics: Theory and Practice of High-Throughput Screening Against Chemical Libraries
SBS has launched a new web-based program designed to provide understanding of specific topics of interest in drug discovery.
News
Cequent Pharmaceuticals Goes Live with Coupa E-Procurement
Coupa e-Procurement enables Cequent to exercise greater control of its purchasing practices and streamline its procurement processes.
News
Symyx Technologies to Acquire MDL Information Systems from Elsevier
Symyx to acquire certain content and software products of MDL Information Systems for $123 million in cash from Elsevier.
News
Tecan Systems Handle High Throughput Prediction of Cancer Recurrence
Genomic Health Inc researchers have chosen Tecan’s liquid handling workstations to automate the multi-gene expression assay that predicts recurrence of cancer.
News
SVS Independently Validates IDBS’ E-WorkBook Suite against 21 CFR Part 11 and GLP Requirements
IDBS has announced that its complete E-WorkBook Suite has been independently validated by the Sociedad de Validacion de Sistemas, (SVS).
News
TTP LabTech Announce US Expansion to Meet Growing Customer Demand
TTP LabTech further expands its US facilities with the recruitment of sales and customer service personnel for its East Coast office in Cambridge, MA.
News
ALA Launches Spotlight Series in Partnership with Symyx Technologies and Thermo Fisher Scientific
The ALA Spotlight Series offers complimentary one-day scientific, results-based educational programs that highlight putting automation to work.
News
Improved Prediction of Prostate Cancer Recurrence through Systems Pathology
Aureon Laboratories and their collaborators publish their 'Systems Pathology' model for predicting prostate cancer PSA recurrence in the Journal of Clinical Investigation.
News
Personalized Medicine: Milestone in the Therapy Control of Humanized Antibodies
CENiMED, BioTeZ and Invitek announce their cooperation to develop, produce and market the Recovery-ELISAs for the therapy control of humanized antibodies.
Advertisement